Breast cancer vaccines: current research and future prospects

Research output: Contribution to journalArticlepeer-review


Although the immune system can clearly recognize cancer cells, there is little evidence that it does so to any effective consequence in patients with advanced breast cancer. The possibility of effective control of micrometastatic disease remains but is unproven. The challenge for the clinician is to find ways to enhance the ability of a patient's own immune system to recognize and effectively target malignant cells. It is clear that there is no shortage of target antigens for immune cell recognition of breast cancer but it is less certain whether the route to an effective therapeutic strategy lies with enhanced recognition of an individual target or a more general route to enhanced immune cell activation.
Original languageEnglish
Pages (from-to)29-34
Number of pages6
JournalExpert Review of Vaccines
Issue number1
Publication statusPublished - Jun 2002


  • Breast Neoplasms
  • Cancer Vaccines
  • Female
  • Humans
  • Immunotherapy
  • Mucin-1
  • Peptide Fragments
  • Receptor, erbB-2
  • Vaccination


Dive into the research topics of 'Breast cancer vaccines: current research and future prospects'. Together they form a unique fingerprint.

Cite this